4DMedical is trading at A$4.31, up 13.42%, amid broader global risk-on sentiment after market recovery.

  • Presented its lung-imaging platform at the Life Sciences Virtual Investor Forum, highlighting expansion across the United States, Europe, veterans’ care, and pulmonary-embolism imaging.
  • The September 18 move was primarily attributed to risk-on sentiment; no new September 21 company announcement was identified.
  • The rally extends recent volatility, including gains on September 15 and September 17.